Skip to main content
. 2020 May 11;20:648. doi: 10.1186/s12889-020-08781-8

Table 3.

Heart failure specific medications

Ivabradine
Ethacrynic acid
Eplerenone
Bisoprolol
Nebivolol
Carvedilol
Metoprolol succinate (HF doses onlya)
Sacubitril / Valsartan

Source: SHAPE Project Collaborators Expert Opinion, September 2018

In Australia, these medications have a restricted use benefit in the Pharmaceutical Benefits Scheme to ‘moderate to severe heart failure’ only. For example: https://www.pbs.gov.au/medicine/item/8733P for metoprolol succinate

aDoses 23.75 mg, 47.5 mg, 95 mg, 190 mg (controlled release)